Most Awaited Q3 Sale is back. Upto 30% discount on every report.
Antithrombin Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 25
SKU : PH4035
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
Multiple User
Enterprise User
Request new version
FAQ’s
What is the Projected CAGR value of the Antithrombin Market?
The Antithrombin Market is expected to grow at a CAGR of 4.6% during the forecast period.
Who are the key players in Antithrombin Market?
Key players are CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc, Siemens AG, Thermo Fisher Scientific, Lee Biosolutions Inc., BDI Pharma, among others.
Which is the fastest-growing region in the Antithrombin Market?
Asia Pacific is the fastest-growing region in the Antithrombin Market.
Which is the Largest Market Share in the Antithrombin Market?
North America is the Largest Market Share in Antithrombin Market.
Related Reports
pharmaceuticalsPOEMS Syndrome Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 06
Starting from
$4350
pharmaceuticalsNeutropenia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 26
Starting from
$4350
pharmaceuticalsHypereosinophilic Syndrome Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 29
Starting from
$4350
pharmaceuticalsChronic Eosinophilic Leukemia Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsBleeding Disorders Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 26
Starting from
$4350
pharmaceuticalsLiposarcoma Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350